Submitted:
09 December 2025
Posted:
10 December 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Materials
2.2. Instruments
2.3. Experimental Methods
2.3.1. Formula One (F1). AgNP Synthesis Using Trisodium Citrate as a Reducing Agent
2.3.2. Formula Two (F2). AgNP Synthesis Using Sodium Borohydride as Reducing Agent
2.3.3. Formula Three (F3). AgNP Synthesis by a Combined Method Using Sodium Borohydride as Primary Reductant and Trisodium Citrate as Secondary Reductant
2.3.4. Formula Four (F4). AgNP Synthesis by a Combined Method Using Trisodium Citrate and Sodium Borohydride as Reducing Agent in the Presence of Hydrogen Peroxide
2.3.5. Formula Five (F5). AgNP Synthesis Using Polyethylene Glycol as a Reducing Agent
2.4. Purification
2.5. Chemical Characterization
2.6. Microbiological Characterization of AgNP Formulations
2.6.1. Collection of Bacterial Strains
2.6.2. Well Diffusion Assay
2.6.3. Determination of Minimum Bactericidal Concentration (MBC)
3. Results and Discussions
3.1. Quantitative Analysis
3.2. Thermogravimetric Analysis
3.3. Morphological Analysis
3.4. Stability Analysis
3.5. Bactericidal Efficacy of AgNPs
3.6. Antibacterial Activity of AgNPs
3.7. Interpretation of Findings
4. Conclusion
Data Availability Statement
Conflict of Interest
Abbreviations
References
- Murray, CJL; Ikuta, KS; Sharara, F; Swetschinski, L; Robles Aguilar, G; Gray, A; et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 2022, 399(10325), 629–55. [Google Scholar] [CrossRef]
- WHO. Global antibiotic resistance surveillance report 2025 2025 [updated October 13, 2025. 1 December 2025. Available online: https://www.who.int/publications/i/item/9789240116337/.
- Sondi, I; Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. Journal of colloid and interface science 2004, 275(1), 177–82. [Google Scholar] [CrossRef] [PubMed]
- Marambio-Jones, C; Hoek, EMV. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. Journal of Nanoparticle Research 2010, 12(5), 1531–51. [Google Scholar] [CrossRef]
- Morones, JR; Elechiguerra, JL; Camacho, A; Holt, K; Kouri, JB; Ramírez, JT; et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16(10), 2346–53. [Google Scholar] [CrossRef]
- Prabhu, S; Poulose, EK. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. International Nano Letters 2012, 2(1), 32. [Google Scholar] [CrossRef]
- Rai, M; Yadav, A; Gade, A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009, 27(1), 76–83. [Google Scholar] [CrossRef] [PubMed]
- Pal, S; Tak, YK; Song, JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Applied and environmental microbiology 2007, 73(6), 1712–20. [Google Scholar] [CrossRef]
- Guzman, M; Dille, J; Godet, S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria; nanotechnology, biology, and medicine: Nanomedicine, 2012; Volume 8, 1, pp. 37–45. [Google Scholar]
- Ansari, MA; Khan, HM; Khan, AA; Ahmad, MK; Mahdi, AA; Pal, R; et al. Interaction of silver nanoparticles with Escherichia coli and their cell envelope biomolecules. Journal of basic microbiology 2014, 54(9), 905–15. [Google Scholar] [CrossRef]
- Smith, DE; Dhinojwala, A; Moore, FB-G. Effect of substrate and bacterial zeta potential on adhesion of Mycobacterium smegmatis. Langmuir 2019, 35(21), 7035–42. [Google Scholar] [CrossRef]
- Tripathi, N; Goshisht, MK. Recent advances and mechanistic insights into antibacterial activity, antibiofilm activity, and cytotoxicity of silver nanoparticles. ACS Applied Bio Materials 2022, 5(4), 1391–463. [Google Scholar] [CrossRef] [PubMed]
- Franci, G; Falanga, A; Galdiero, S; Palomba, L; Rai, M; Morelli, G; et al. Silver nanoparticles as potential antibacterial agents. Molecules (Basel, Switzerland) 2015, 20(5), 8856–74. [Google Scholar] [CrossRef]
- Pareek, V; Gupta, R; Panwar, J. Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review. Materials Science and Engineering: C 2018, 90, 739–49. [Google Scholar] [CrossRef]
- Le Ouay, B; Stellacci, F. Antibacterial activity of silver nanoparticles: A surface science insight. Nano today 2015, 10(3), 339–54. [Google Scholar] [CrossRef]
- Ahmad, A; Wei, Y; Syed, F; Tahir, K; Rehman, AU; Khan, A; et al. The effects of bacteria-nanoparticles interface on the antibacterial activity of green synthesized silver nanoparticles. Microbial pathogenesis 2017, 102, 133–42. [Google Scholar] [CrossRef]
- Menichetti, A; Mavridi-Printezi, A; Mordini, D; Montalti, M. Effect of Size, Shape and Surface Functionalization on the Antibacterial Activity of Silver Nanoparticles. Journal of Functional Biomaterials 2023, 14(5), 244. [Google Scholar] [CrossRef]
- Gudikandula, K; Charya Maringanti, S. Synthesis of silver nanoparticles by chemical and biological methods and their antimicrobial properties. Journal of Experimental Nanoscience 2016, 11(9), 714–21. [Google Scholar] [CrossRef]
- Restrepo, CV; Villa, CC. Synthesis of silver nanoparticles, influence of capping agents, and dependence on size and shape: A review. Environmental Nanotechnology, Monitoring & Management 2021, 15, 100428. [Google Scholar] [CrossRef]
- Pillai, ZS; Kamat, PV. What factors control the size and shape of silver nanoparticles in the citrate ion reduction method? The Journal of Physical Chemistry B 2004, 108(3), 945–51. [Google Scholar] [CrossRef]
- Tang, S; Zheng, J. Antibacterial activity of silver nanoparticles: structural effects. Advanced healthcare materials 2018, 7(13), 1701503. [Google Scholar] [CrossRef]
- Samberg, ME; Orndorff, PE; Monteiro-Riviere, NA. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 2011, 5(2), 244–53. [Google Scholar] [CrossRef] [PubMed]
- Dong, X; Ji, X; Wu, H; Zhao, L; Li, J; Yang, W. Shape Control of Silver Nanoparticles by Stepwise Citrate Reduction. The Journal of Physical Chemistry C 2009, 113(16), 6573–6. [Google Scholar] [CrossRef]
- Mulfinger, L; Solomon, SD; Bahadory, M; Jeyarajasingam, AV; Rutkowsky, SA; Boritz, C. Synthesis and Study of Silver Nanoparticles. Journal of Chemical Education 2007, 84(2), 322. [Google Scholar] [CrossRef]
- Brown, AN; Smith, K; Samuels, TA; Lu, J; Obare, SO; Scott, ME. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Applied and environmental microbiology 2012, 78(8), 2768–74. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Q; Li, N; Goebl, J; Lu, Z; Yin, Y. A systematic study of the synthesis of silver nanoplates: is citrate a "magic" reagent? Journal of the American Chemical Society 2011, 133(46), 18931–9. [Google Scholar] [CrossRef]
- de Oliveira, JFA; Saito, A; Bido, AT; Kobarg, J; Stassen, HK; Cardoso, MB. Defeating Bacterial Resistance and Preventing Mammalian Cells Toxicity Through Rational Design of Antibiotic-Functionalized Nanoparticles. Scientific reports 2017, 7(1), 1326. [Google Scholar] [CrossRef]










|
Formula (Reducing Agent) |
Electrical Conductivity |
Total Dissolved Solid (Solution Volume = 30 ml) |
Zeta Potential |
Particle Size (Diameter) |
|
Formula-1 (TSC) |
818 µS | 314 ppm | -39.4 mV | 87.15 nm |
|
Formula-2 (NaBH4) |
848 µS | 176 ppm | -29.1 mV | 91.71 nm |
|
Formula-3 (NaBH4 & TSC) |
779 µS | 297 ppm | -41.1 mV | 65.07 nm |
|
Formula-4 (NaBH4 & TSC, H2O2) |
758 µS | 609 ppm | -36.7 mV | 30.91 nm |
|
Formula-5 (PEG & PVP) |
871 µS | 191 ppm | -8.0 mV | 93.85 nm |
| AgNP Formula | Number of Colonies | |||||
| Concentration | 0 PPM | 5 PPM | 10 PPM | 20 PPM | 40 PPM | |
| Formula- 1 | 402 | 7 | 2 | 1 | 0 | |
| Formula- 2 | 402 | 39 | 10 | 8 | 0 | |
| Formula- 3 | 402 | 106 | 8 | 6 | 4 | |
| Formula- 4 | 402 | 395 | 176 | 18 | 4 | |
| Formula- 5 | 402 | 71 | 4 | 2 | 0 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).